December 15, 2008 - Lantheus Medical Imaging reported that new data from a retrospective, multicenter, cohort study of over four million hospitalized patients showed similar unadjusted mortality rates for patients receiving DEFINITY Vial for (Perflutren Lipid Microsphere) Injectable Suspension enhanced resting echocardiography exams when compared with patients who did not receive DEFINITY.

December 15, 2008 - Visage Imaging Inc. has received FDA 510(k) clearance to market its latest thin-client product release, Visage CS 3.1, which boasts significant enhancements to its prior offerings in cardiac and other tools, and includes new optional applications for neurology and oncology.

The neuro option facilitates brain perfusion analysis in CT and MRI imaging, while the oncology option provides tools for analyzing, documenting, and comparing lesions for multiple modalities, including Standardized Update Value (SUV)-based analysis for PET-CT.

December 15, 2008 - Boston Scientific Corp. today announced FDA approval of its Express SD Renal Monorail Premounted Stent System for use as an adjunct to PTRA (percutaneous transluminal renal angioplasty) in certain lesions of the renal arteries.

The Express SD System is the first low-profile, pre-mounted stent approved for use in renal arteries in the U.S., and is the only FDA-approved renal stent designed to provide additional proximal end support, says Boston Scientific.

December 15, 2008 - Terumo Corp. and its subsidiary, Terumo Cardiovascular Systems Corp., announced they have entered into an agreement to settle all outstanding litigation with Maquet Cardiovascular LLC.

The companies have a number of lawsuits pending in which each claims the other has infringed its patents. The litigations all involve methods and devices used in endoscopic vessel harvesting. All pending disputes between the companies will be immediately dismissed. In addition, the companies have agreed to cross license certain patents.

December 15, 2008 - In regions of the country where cardiologists perform high numbers of cardiac catheterizations to diagnose heart problems, patients may be receiving percutaneous cardiac interventions (PCI) more than they need or want, according to a study published online last week in the journal Circulation.

December 15, 2008 - Two additional hospitals in the U.S. opened patient enrollment for CardioVascular BioTherapuetics Inc.’s ACORD Phase II clinical trial for the treatment of severe coronary heart disease.
The sites are Minneapolis Heart Institute Foundation in Minneapolis MN, and Princeton Baptist Medical Center in Birmingham, AL.
Mercy Hospital Fairfield (Ohio) and The Christ Hospital in Cincinnati, OH were first to open for enrollment in early September, and are working in collaboration to screen and treat patients in the trial.

December 12, 2008 – IQ•SPECT is the newest Symbia feature from Siemens Healthcare that reportedly enables a comprehensive cardiac evaluation including perfusion, attenuation correction and calcium scoring in just five minutes.

December 10, 2008 - New research has found that the availability of a portable eight-slice computed tomography (CT) scanner in an emergency room can significantly increase the number of stroke victims who receive a potentially life-saving treatment, according to results of a study conducted at North Shore Medical Center (NSMC)-Salem Hospital in Salem, MA, and presented at the annual meeting of the Radiological Society of North America (RSNA).

December 12, 2008 - Cardiac Advancements LLC, a provider of remote cardiac monitoring services and products, and Cardiostaff Corp. have partnered to provide enhance cardiac care across the nation.

Cardiostaff provides physician practices and hospitals with 24/7 patient arrhythmia information for patient diagnosis and arrhythmia therapy management. Services include: 30-Day event monitoring, digital holter monitoring, atrial fibrillation monitoring, pacemaker follow-up and remote telemetry monitoring.

IQ-SPECT is the newest Symbia feature from Siemens Healthcare that reportedly enables a comprehensive cardiac evaluation including perfusion, attenuation correction and calcium scoring in just five minutes.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now